Evidence map›Paper›PMID 23543606›Full record

ReviewAAPS PharmSciTech2013

A review of polymeric refabrication techniques to modify polymer properties for biomedical and drug delivery applications.

Viness Pillay, Ahmed Seedat, Yahya E Choonara, Lisa C du Toit, Pradeep Kumar, Valence M K Ndesendo

Abstract readReview
In one paragraph

Review in AAPS PharmSciTech, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Biodegradable Gg-RSC advances · 2023
    Article
  5. Review
  6. Surface Modification of ZrONanomaterials (Basel, Switzerland) · 2022
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Viness PillayDepartment of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, 2193, Johannesburg, South Africa. Viness.Pillay@wits.ac.za
Ahmed Seedat
Yahya E Choonara
Lisa C du Toit
Pradeep Kumar
Valence M K Ndesendo

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polymers are extensively used in the pharmaceutical and medical field because of their unique and phenomenal properties that they display. They are capable of demonstrating drug delivery properties that are smart and novel, such properties that are not achievable by employing the conventional excipients. Appropriately, polymeric refabrication remains at the forefront of process technology development in an endeavor to produce more useful pharmaceutical and medical products because of the multitudes of smart properties that can be attained through the alteration of polymers. Small alterations to a polymer by either addition, subtraction, self-reaction, or cross reaction with other entities have the capability of generating polymers with properties that are at the level to enable the creation of novel pharmaceutical and medical products. Properties such as stimuli-responsiveness, site targeting, and chronotherapeutics are no longer figures of imaginations but have become a reality through utilizing processes of polymer refabrication. This article has sought to review the different techniques that have been employed in polymeric refabrication to produce superior products in the pharmaceutical and medical disciplines. Techniques such as grafting, blending, interpenetrating polymers networks, and synthesis of polymer complexes will be viewed from a pharmaceutical and medical perspective along with their synthetic process required to attain these products. In addition to this, each process will be evaluated according to its salient features, impeding features, and the role they play in improving current medical devices and procedures.

Indexed as

Biocompatible MaterialsDrug CarriersAnimalsChemistry, PharmaceuticalDelayed-Action PreparationsHumansMolecular StructurePharmaceutical PreparationsPolymersSolubilityStructure-Activity RelationshipTechnology, PharmaceuticalTemperatureTissue EngineeringBiocompatible MaterialsDelayed-Action PreparationsDrug CarriersPharmaceutical PreparationsPolymers

Identifiers

PMID23543606
PMCPMC3665995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.